Cancer study a world first

A research study to recruit foreign language speaking cancer patients through Australian Cancer Registries will begin in New South Wales this month.

The study aims to assess anxiety, depression and quality of life in Greek, Chinese and Arabic speaking cancer patients in Australia. It will also document unmet needs and patterns of care throughout their cancer journey.

The University of Sydney will conduct the study in four Australian States and plan to survey 1,000 cancer patients.

Study participants will be adults aged 18-80, diagnosed with cancer between 2005 and 2006 and born in nations speaking Chinese (Mandarin or Cantonese), Arabic or Greek, and currently resident in Australia.

Cancer patients from culturally and linguistically diverse backgrounds have poorer quality of life following cancer treatment. They may experience difficulties within the Australian health system due to language barriers, poor knowledge of the healthcare system, differing beliefs and religion and social disadvantage.

The study's Chief Investigator Professor Phyllis Butow said: "This will be the first study in the world to systematically explore outcomes in CALD (culturally and linguistically diverse) cancer patients using rigorous and culturally appropriate methodologies.

"Based on the information received from the survey, it will be possible to plan appropriate and targeted interventions, which we hope will lead to an increased quality of life following cancer treatment for these vulnerable populations.

"This information will be invaluable to all services wishing to provide culturally appropriate care for their cancer patients", Professor Butow said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered tool predicts gene activity in cancer cells from biopsy images